Contraceptives Market .pdf
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Transparency <strong>Market</strong>Research<strong>Contraceptives</strong> <strong>Market</strong> - Global Industry Analysis, Size,Share, Growth, Trends and Forecast 2014 – 2020Published Date17-12-2014106 Page ReportBuy NowRequest SamplePress ReleaseGlobal <strong>Contraceptives</strong> <strong>Market</strong> to Grow to US$19.6 Billion, APACto DominateTransparency <strong>Market</strong> ResearchState Tower,90, State Street, Suite 700.Albany, NY 12207United Stateswww.transparencymarketresearch.comsales@transparencymarketresearch.com
<strong>Contraceptives</strong> <strong>Market</strong>REPORT DESCRIPTIONA new report published by Transparency <strong>Market</strong> Research (TMR) has published a report titled“<strong>Contraceptives</strong> <strong>Market</strong> - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014- 2020”. The report studies the strengths, weaknesses, opportunities, and threats that abound inthis market. According to the report, the global contraceptives market was valued at US$15.7billion in 2013 and is expected to reach a value of US$19.6 billion in 2020, growing at a CAGR of3.1% from 2014 to 2020. It also offers expert advice on the growth of this market, the factorslikely to support the same, and the ones that will inhibit its growth.Browse the full <strong>Contraceptives</strong> <strong>Market</strong> (Oral Contraceptive Pills, ContraceptiveInjectables, Topical <strong>Contraceptives</strong>, Male Condoms, Female Condoms, IntrauterineDevices, Sub-Dermal Contraceptive Implants, Contraceptive Vaginal Rings,Contraceptive Diaphragms, Contraceptive Sponges, Non-Surgical PermanentContraception Devices) - Global Industry Analysis, Size, Share, Growth, Trends andForecast 2014 - 2020 report at:http://www.transparencymarketresearch.com/contraceptives-market.html<strong>Contraceptives</strong> are drugs and devices that enable prevention of an unwanted pregnancy. Theother important function of the devices is to prevent transfer of sexually transmitted diseases orinfections. Initiatives taken by the government and organizations to control population andpromote safer sex are the main growth drivers for the global contraceptives market. The globalcontraceptives market is segmented by products and geography. The products segment isfurther broken down into drugs, such as topical contraceptives, injectables, and oralcontraceptive pills. The next sub-segment is devices, which consists of male contraceptivedevices (such as condoms) and female contraceptive devices such as female condoms, subdermalcontraceptive implants, contraceptive vaginal rings, intrauterine devices, contraceptivediaphragm, contraceptive sponges, and non-surgical permanent contraception device.Geographically, the global contraceptives market is fragmented into North America, Europe, AsiaPacific, and Rest of the World.Request a Brochure of this :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=344Transparency <strong>Market</strong> Research2
<strong>Contraceptives</strong> <strong>Market</strong>Out of all these segments, contraceptive devices held the biggest market share, at about 60%, in2013. This segment owes its huge success to the popularity of devices such as copper IUDs,male condoms, and inexpensive sub-dermal contraceptive implants such as sino-implants. By2020, the contraceptive devices segment is expected to grow at a CAGR of more than 3.5%. Thecontraceptives market is expected to witness a steady growth rate; the introduction of femalecondoms such as Bayer’s Skyla in the U.S. market and Jaydess in the European market willencourage this segment to expand in newer directions. Additionally, reduction in the price ofJadelle, a subdermal implant by Bayer HealthCare will also support the contraceptives market inthe coming few years.Browse the full Press Release:http://www.transparencymarketresearch.com/pressrelease/contraceptives-market.htmIn terms of geography, North America held a dominant market share of more than 40% in 2013.However, Asia Pacific is expected to dominate this region with a CAGR of 4.5% in the forecastperiod. Countries such as India and China will contribute significantly to this phenomenon withtheir huge population base, rising disposable incomes, and growing awareness about the usageof contraceptives.Some of the major market players profiled in this report are Bayer AG, Actavis Inc.,CooperSurgical Inc., Church & Dwight Co. Inc., Mayer Laboratories Inc., Merck & Co. Inc., ReckittBenckiser plc, Pfizer Inc., The Female Health Company, and Teva Pharmaceutical Industries Ltd.TABLE OF CONTENTChapter 1 Introduction1.1 Report Description1.2 <strong>Market</strong> SegmentationTransparency <strong>Market</strong> Research3
<strong>Contraceptives</strong> <strong>Market</strong>1.3 Research Methodology1.4 List of AbbreviationsChapter 2 Executive Summary2.1 <strong>Market</strong> Snapshot: Global <strong>Contraceptives</strong> <strong>Market</strong>2.2 Comparative Analysis: Global <strong>Contraceptives</strong> <strong>Market</strong>, by Geography, 2013 & 2020 (Value %)Chapter 3 Global <strong>Contraceptives</strong> <strong>Market</strong> Overview3.1 Introduction3.2 <strong>Market</strong> Dynamics3.2.1 <strong>Market</strong> Drivers3.2.1.1 High incident rate of unintended pregnancies is leading to unmet contraceptive needs,hence driving the contraceptives marketglobally3.2.1.2 Awareness programs by government and NGOs are promoting the use of contraceptives3.2.1.3 Implementation of the Patient Protection Act or the Affordable Care Act increased the useof contraceptives in North America3.2.2 <strong>Market</strong> Restraints3.2.2.1 Side effects associated with the use of contraceptive drugs and devices induce people toopt for natural and permanent contraceptive methods3.2.2.2 Rising prevalence of infertility among women and aging population are limiting the use ofcontraceptives3.2.2.3 Ethical and social issues restrict the use or subsidies on contraceptives in some countriesTransparency <strong>Market</strong> Research4
<strong>Contraceptives</strong> <strong>Market</strong>3.2.3 <strong>Market</strong> Opportunities3.2.3.1 Presence of large unmet contraceptive needs in emerging Asian and African Economieswould drive the contraceptives market3.2.3.2 Presence of strong contraceptive pipeline would support the global contraceptives marketduring the forecast period3.3 Porter’s Five Forces Analysis: Global <strong>Contraceptives</strong> <strong>Market</strong>3.3.1 Bargaining Power of Suppliers3.3.2 Bargaining Power of Buyers3.3.3 Threat of Substitutes3.3.4 Threat of New Entrants3.3.5 Competitive Rivalry3.4 <strong>Market</strong> Attractiveness Analysis: Global <strong>Contraceptives</strong> <strong>Market</strong>, by Geography3.5 Competitive Landscape: Global <strong>Contraceptives</strong> <strong>Market</strong>, by Key Players3.5.1 Heat Map Analysis for Key <strong>Market</strong> Players: Global Contraceptive Drugs <strong>Market</strong>3.5.2 Heat Map Analysis for Key <strong>Market</strong> Players: Global Contraceptive Devices <strong>Market</strong>Chapter 4 Global <strong>Contraceptives</strong> <strong>Market</strong>, by Product Type4.1 Introduction4.1.1 Comparative Analysis: Global <strong>Contraceptives</strong> <strong>Market</strong> Revenue, by Product Type, 2013 & 2020 (%)4.2 Contraceptive Drugs4.2.1 Global Contraceptive Drugs <strong>Market</strong> Revenue, by Drug Type, 2012 – 2020 (USD Million)Transparency <strong>Market</strong> Research5
<strong>Contraceptives</strong> <strong>Market</strong>4.2.2 Oral Contraceptive Pills4.2.2.1 Global Oral Contraceptive Pills <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)4.2.3 Contraceptive Injectables4.2.3.1 Global Contraceptive Injectables <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)4.2.4 Topical <strong>Contraceptives</strong>4.2.4.1 Global Topical <strong>Contraceptives</strong> <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)4.3 Contraceptive Devices4.3.1 Comparative Analysis: Global Contraceptive Devices <strong>Market</strong>, by Device Type, 2013 & 2020 (%)4.3.2 Male Contraceptive Devices (Male Condoms)4.3.2.1 Global Male Contraceptive Devices <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)4.3.2.2 Competitive Landscape: Global Male Contraceptive Devices (Male Condoms) Segment4.3.3 Female Contraceptive DevicesMillion)4.3.3.1 Global Female Contraceptive Devices <strong>Market</strong> Revenue, by Device Type, 2012 – 2020 (USD4.3.3.2 Female Condoms4.3.3.2.1 Global Female Condoms <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)4.3.3.3 Contraceptive Diaphragms4.3.3.3.1 Global Contraceptive Diaphragms <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)4.3.3.4 Contraceptive Sponges4.3.3.4.1 Global Contraceptive Sponges <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)4.3.3.5 Contraceptive Vaginal RingsTransparency <strong>Market</strong> Research6
<strong>Contraceptives</strong> <strong>Market</strong>4.3.3.5.1 Global Contraceptive Vaginal Rings <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)4.3.3.6 Intrauterine Devices4.3.3.6.1 Global Intrauterine Devices <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)4.3.3.7 Subdermal Contraceptive Implants4.3.3.7.1 Global Subdermal Implants <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)4.3.3.8 Non-Surgical Permanent Contraception Devices2020 (USD Million)4.3.3.8.1 Global Non-Surgical Permanent Contraception Devices <strong>Market</strong> Revenue, 2012 –Chapter 5 Global <strong>Contraceptives</strong> <strong>Market</strong>, by Geography5.1 Overview5.1.1 Global <strong>Contraceptives</strong> <strong>Market</strong> Revenue, by Geography, 2012 – 2020 (USD Million)5.2 North America5.2.1 North America <strong>Contraceptives</strong> <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)5.2.2 North America <strong>Contraceptives</strong> <strong>Market</strong>, by Products (Drugs & Devices), 2012 – 2020 (USD Million)5.3 Europe5.3.1 Europe <strong>Contraceptives</strong> <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)5.3.2 Europe <strong>Contraceptives</strong> <strong>Market</strong>, by Products (Drugs & Devices), 2012 – 2020 (USD Million)5.4 Asia Pacific5.4.1 Asia Pacific <strong>Contraceptives</strong> <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)5.4.2 Asia Pacific <strong>Contraceptives</strong> <strong>Market</strong>, by Products (Drugs & Devices), 2012 – 2020 (USD Million)Transparency <strong>Market</strong> Research7
<strong>Contraceptives</strong> <strong>Market</strong>5.5 Rest of the World (RoW)5.5.1 Rest of the World <strong>Contraceptives</strong> <strong>Market</strong> Revenue, 2012 – 2020 (USD Million)Million)5.5.2 Rest of the World <strong>Contraceptives</strong> <strong>Market</strong>, by Products (Drugs & Devices), 2012 – 2020 (USDChapter 6 Recommendations6.1 Investing in Emerging Economies such as India and China and Underdeveloped African Economies6.2 Making Rigorous R&D Initiatives6.3 Investing in <strong>Market</strong>ing Campaigns to Elevate Customer Awareness6.4 Tracking Patent Expiration of Branded ProductsChapter 7 Company Profiles7.1 Actavis, Inc.7.1.1 Company Overview7.1.2 Financial Overview7.1.3 Product Portfolio7.1.4 Business Strategies7.1.5 Recent Developments7.2 Bayer AG7.2.1 Company Overview7.2.2 Financial OverviewTransparency <strong>Market</strong> Research8
<strong>Contraceptives</strong> <strong>Market</strong>7.2.3 Product Portfolio7.2.4 Business Strategies7.2.5 Recent Developments7.3 Church & Dwight Co., Inc.7.3.1 Company Overview7.3.2 Financial Overview7.3.3 Product Portfolio7.3.4 Business Strategies7.3.5 Recent Developments7.4 CooperSurgical, Inc.7.4.1 Company Overview7.4.2 Financial Overview7.4.3 Product Portfolio7.4.4 Business Strategies7.4.5 Recent Developments7.5 Mayer Laboratories, Inc.7.5.1 Company Overview7.5.2 Financial Overview7.5.3 Product Portfolio7.5.4 Business Strategies7.5.5 Recent DevelopmentsTransparency <strong>Market</strong> Research9
<strong>Contraceptives</strong> <strong>Market</strong>7.6 Merck & Co., Inc.7.6.1 Company Overview7.6.2 Financial Overview7.6.3 Product Portfolio7.6.4 Business Strategies7.6.5 Recent Developments7.7 Pfizer, Inc.7.7.1 Company Overview7.7.2 Financial Overview7.7.3 Product Portfolio7.7.4 Business Strategies7.7.5 Recent Developments7.8 Reckitt Benckiser plc7.8.1 Company Overview7.8.2 Financial Overview7.8.3 Product Portfolio7.8.4 Business Strategies7.8.5 Recent Developments7.9 Teva Pharmaceutical Industries Ltd.7.9.1 Company Overview7.9.2 Financial OverviewTransparency <strong>Market</strong> Research10
<strong>Contraceptives</strong> <strong>Market</strong>7.9.3 Product Portfolio7.9.4 Business Strategies7.9.5 Recent Developments7.10 The Female Health Company7.10.1 Company Overview7.10.2 Financial Overview7.10.3 Product Portfolio7.10.4 Business Strategies7.10.5 Recent DevelopmentsAbout UsTransparency <strong>Market</strong> Research is a market intelligence company providing global business informationreports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlookinginsight for thousands of decision makers.We are privileged with highly experienced team of Analysts, Researchers and Consultants, who useproprietary data sources and various tools and techniques to gather, and analyze information. Ourbusiness offerings represent the latest and the most reliable information indispensable for businesses tosustain a competitive edge.ContactTransparency <strong>Market</strong> ResearchTransparency <strong>Market</strong> Research11
<strong>Contraceptives</strong> <strong>Market</strong>90 State Street,Suite 700,AlbanyNY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-552-3453Email: sales@transparencymarketresearch.comWebsite: http://www.transparencymarketresearch.com/Transparency <strong>Market</strong> Research12
Change language